Tudor Investment Corp’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$930K Buy
150,960
+131,655
+682% +$1.09M ﹤0.01% 2420
2025
Q4
$201K Buy
+19,305
New +$194K ﹤0.01% 3296
2025
Q3
Sell
-51,262
Closed -$666K 3807
2025
Q2
$666K Sell
51,262
-36,042
-41% -$542K ﹤0.01% 2401
2025
Q1
$2.2M Buy
87,304
+19,166
+28% +$570K 0.01% 1287
2024
Q4
$2.34M Buy
68,138
+36,669
+117% +$1.65M 0.01% 1151
2024
Q3
$1.56M Sell
31,469
-51,647
-62% -$2.65M 0.01% 1363
2024
Q2
$5M Sell
83,116
-3,886
-4% -$222K 0.03% 664
2024
Q1
$4.49M Buy
+87,002
New +$4.27M 0.03% 645
2023
Q4
Sell
-27,908
Closed -$778K 2829
2023
Q3
$778K Sell
27,908
-57,011
-67% -$1.7M 0.01% 1439
2023
Q2
$2.45M Buy
+84,919
New +$1.89M 0.03% 790

Other funds holding RXST

Tudor Investment Corp's RXST Position: Q1 2026 in Review

Tudor Investment Corp increased its RxSight (RXST) stake by 682% in Q1 2026, buying an estimated $1.09M and bringing the position to 150,960 shares worth $930K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.

Tudor Investment Corp first reported a position in RXST in Q2 2023 and has held it in 10 quarters since. The position peaked at $5M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Tudor Investment Corp held 150,960 shares of RxSight worth $930K as of Q1 2026.
  • Tudor Investment Corp bought 131,655 RxSight shares in Q1 2026, an estimated $1.09M.
  • RxSight made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2420 holding.
  • Tudor Investment Corp first reported a position in RxSight in Q2 2023 and has held it in 10 quarters since.
  • Tudor Investment Corp's RxSight position peaked at $5M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.